The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →“Bone-repairing nanoparticles laced with DNA” refers to an experimental injectable paste reported in 2013—not an established treatment. The material used calcium-phosphate nanoparticles to carry DNA encoding two growth factors, BMP-7 and VEGF. The proposed delivery mechanism is scientifically distinct from proof that the paste repairs bone in people: the cited evidence does not establish clinical effectiveness or availability as a human treatment.
What was the DNA-loaded paste?
A 2013 Chemistry World report described an injectable paste made with synthetic calcium-phosphate nanoparticles. The particles encapsulated DNA carrying genes for two growth factors:
As an Amazon Associate I earn from qualifying purchases.
- BMP-7 (bone morphogenetic protein 7), associated with bone formation.
- VEGF (vascular endothelial growth factor), associated with the growth of blood vessels.
The report covered a material described by S. Chernousova, J. Klesing, N. Soklakova and M. Epple in a 2013 paper in RSC Advances (DOI 10.1039/C3RA23450A). Its focus was a proposed way to deliver growth-factor genes locally, rather than a finished medical product.
Recommended Free Tools
How was it supposed to work?
- Cells near the injection site take up the calcium-phosphate nanoparticles.
- Inside cells, acidic conditions in lysosomes dissolve the calcium phosphate, releasing the encapsulated DNA.
- The transfected cells then produce BMP-7 and VEGF, which are associated with bone formation and blood-vessel growth, respectively.
This is the mechanism proposed for the experimental material in the report. It should not be read as proof that the paste successfully repairs bone in patients.
#1 Best Overall
- Made of deproteinized bovine bone
- Natural origin
- Bone Graft 0.25-1mm
- Chemically and structurally comparable to mineralized cancellous human bone
Why were researchers interested in this approach?
The 2013 report presented the paste in the context of challenges with existing bone-repair options. Matthias Epple, of the University of Duisburg-Essen, said that alternatives including donor bone and synthetic calcium phosphate could raise concerns such as infection, poor mechanical stability or inadequate resorption to make way for new bone. These are the concerns reported in that article, not a claim that every alternative has all of those problems.
Michael Hofmann, a bone-cement and drug-delivery researcher at the University of Birmingham, described the possibility that a bioresorbable paste might be replaced by newly formed bone as a “vanishing implant.” That was an assessment of the material’s potential, not a reported clinical result.
Does the evidence show that it works in people?
No. The cited sources describe experimental materials and laboratory, cell or animal research; they do not establish that the 2013 paste is an effective treatment for people. They also do not establish its approval or availability as a human treatment. The sources do not resolve its regulatory or commercial status in specific jurisdictions.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →Accordingly, claims that this paste heals human fractures, avoids surgery or shortens recovery are not supported by the evidence described here.
How does it relate to later DNA-based bone-repair research?
Later studies explored different materials. They provide context for the broader field, but they are not follow-up proof that the 2013 calcium-phosphate paste became a treatment.
DNA hydrogel study (2024)
A 2024 study in Bioactive Materials reported a polymer-modified DNA hydrogel containing Aptamer02-modified tetrahedral framework nucleic acid. It described cell experiments and experiments in rats with critical-size cranial defects. The paper’s background says typical DNA hydrogels have a gelation-temperature limitation of about 46 °C, while the authors’ design gels at 37 °C. These are material and preclinical findings, not patient outcome figures.
Rank #4
Scaffold and hydrogel study (2022)
A 2022 study described a different construct: a dynamic DNA hydrogel enabled by black-phosphorus nanosheets and integrated with a 3D-printed scaffold. The authors reported cell experiments and a rat cranial-defect model. This is a separate design from the 2013 nanoparticle paste.
Broader research context (2026)
A 2026 review surveys polymeric and macromolecular nanotherapeutics for bone repair, including metal, polymer and ceramic nanoparticles and nanovehicles. A review of a wider research area does not establish that the 2013 paste is available or clinically proven.
Best Value
- We offer this unique design of the implant-bone mixing well with a lid.
- It is a 1.25” high basin with a silicone rubber ring at the base to make it slip resistant.
- The base is slightly wider than the top portion to offer a better grip on the surface.The lid gently fits on it to keep it safe from the environment.
- We designed it heavier to resist its accidental displacement or drop.
- It is a high-quality stainless steel product that is rust-resistant and autoclavable.
What should readers take away?
The 2013 work proposed using calcium-phosphate nanoparticles to carry DNA instructions for growth factors to cells near a bone defect. That idea, and later DNA-based hydrogels and scaffolds, belongs to experimental biomaterials research. The cited evidence does not show that these materials are established treatments for people.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
